Navigation Links
Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer
Date:1/20/2009

creased 4-fold to 86 days compared to untreated animals, and was significantly better than all controls, including irinotecan administered at its maximum tolerated dose, which is a 50-fold increase in the amount of free drug than SN-38 in the immunoconjugate dose.

"We believe these results suggest that targeted chemotherapy of colorectal cancer with labetuzumab-SN-38 should enhance the bioavailability and reduce the toxicity of the clinically validated drug, irinotecan," commented Cynthia L. Sullivan, President and CEO. "More preclinical evidences are being collected to support the human testing of this new drug immunoconjugate," she added.

About Immunomedics

Immunomedics is a New Jersey-based biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. We have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or "naked" form, or conjugated with radioactive isotopes, chemotherapeutics or toxins, in each case to create highly targeted agents. Using these technologies, we have built a pipeline of therapeutic product candidates that utilize several different mechanisms of action. We also have a majority ownership in IBC Pharmaceuticals, Inc., which is developing a novel Dock-and-Lock (DNL) methodology for making fusion proteins and multifunctional antibodies, and a new method of delivering imaging and therapeutic agents selectively to disease, especially different solid cancers (colorectal, lung, pancreas, etc.), by proprietary, antibody-based, pretargeting methods. We believe that our portfolio of intellectual property, which includes approximately 134 patents issued in the United States and more than 300 other patents issued worldwide, protects our product candidates and technologie
'/>"/>

SOURCE Immunomedics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
2. Kyowa Hakko Kirin Announces Development Policy for Anti-Parkinsons Disease Drug KW-6002 (Istradefylline)
3. Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
4. Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University
5. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
6. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
7. Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse
8. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
9. Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
10. ProUroCare Medical Inc. Announces Pricing of Equity Offering
11. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... -- Organovo Holdings, Inc. (NYSE MKT: ONVO) today announced preliminary ... year ended March 31, 2015. Based on ... March 31, 2015, Organovo estimates: , Total ... and approximately $571 thousand for the fiscal year , ... and fiscal year ended March 31, 2015 of approximately ...
(Date:4/21/2015)... --Algae International Group, Inc. ( ALGA ), through its ... exceptional Hempster T-Shirt sales following yesterday,s online sales launch. ... introduced four t-shirt designs specific to the ,Hempster Clothing, ... the online sales of these first four t-shirts over ... to the  Marijuana Policy Project  (MPP), an organization dedicated ...
(Date:4/21/2015)... April 21, 2015 Global cap ... World demand for caps and closures will exceed $55 billion ... exceed two trillion annually. Beverages will continue to account for ... and a number of smaller markets are expected to register ... Although the most developed markets -- the US, ...
Breaking Medicine Technology:Organovo Holdings, Inc. Pre-Announces Preliminary Fiscal 2015 Fourth Quarter And Year End Financial Information 2Organovo Holdings, Inc. Pre-Announces Preliminary Fiscal 2015 Fourth Quarter And Year End Financial Information 3Organovo Holdings, Inc. Pre-Announces Preliminary Fiscal 2015 Fourth Quarter And Year End Financial Information 4American Seed & Oil Company 420 Hempster T-Shirt Sales Soar; Online Sales Launched Yesterday with Start of 420 Week; Over 2000 Shirts Sold So Far 2World Caps & Closures Market 2World Caps & Closures Market 3
(Date:4/21/2015)... Displays & Exhibits, Inc. a division of Absolute ... building industry, announced a management change of the retail ... in Tustin, California.“It is very important to have a ... in quality as offered by overseas trade show accessories ... Adduru is the new manager of Displays & Exhibits ...
(Date:4/21/2015)... Henry Mayo Newhall Hospital, located in California’s ... to automatically send continuation of care documents (CCDs). When ... communication with clinics and other ambulatory practices, they selected ... , “Provider Alert will enable the physician offices ... need to provide continuing care in real time,” said ...
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 22, 2015 ... Pipeline Review, H1 2015” provides comparative analysis ... The report strengthens R&D pipelines by identifying ... and best-in-class products. Complete report with TOC ... , The report also reviews key players ...
(Date:4/21/2015)... 21, 2015 The report ... comparative analysis on the therapeutic development for ... identifying new targets and MOAs to produce ... TOC is available @ http://www.rnrmarketresearch.com/sinusitis-pipeline-review-h1-2015-market-report.html ... players involved in the therapeutic development for ...
(Date:4/21/2015)... Information is the best weapon in the fight for your ... their families with knowledge about living with cancer in his ... Answer" and new website . , In the book, ... diagnosis through treatment and even death. The goal, he says, ... home and in the examination room. , “Cancer patients and ...
Breaking Medicine News(10 mins):Health News:Displays & Exhibits Reveals Tustin, California Showroom Under New Management 2Health News:Henry Mayo Newhall Hospital to Improve Ambulatory Information Sharing with Summit Healthcare's Summit Provider Alert 2Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Authoritative guide and new accompanying therapeutic web portal bridge information gaps in cancer treatment 2
... The following is being issued by Cheryl ... 721 will streamline the health care process for ... long waits and associated, unnecessary costs because they ... treatment."Currently, patients seeking rehabilitation for functional impairments due ...
... experts say, , , THURSDAY, March 5 (HealthDay News) -- Men ... life span by more than two years, Swedish researchers say. ... beneficial effect on length of life as quitting smoking in ... exercise, the researchers said. But Dr. Karl Michaëlsson, a senior ...
... Group, Inc. (OTC Bulletin Board: POLGA ; OTC ... marketer of engineered materials, announced today it will release ... of the market on Wednesday, March 18, 2009. Company ... slides, starting at 10:00 a.m. EDT on Thursday, March ...
... March 5 Despite dermatologists, continual efforts, ... harmful effects of excessive sun exposure and regular use ... to reduce the risk of developing skin cancer. But ... may help encourage them to apply sunscreen regularly via ...
... BRIARCLIFF MANOR, N.Y., March 5 SETO Holdings, Inc. (Pink ... under which it agreed in principle (1) to issue shares ... stock of Advanced Hearing Centers, Inc. ("AHC"), a Maryland corporation ... locations in Maryland and one in Virginia, and (2) to ...
... of infection, study says , , THURSDAY, March 5 (HealthDay News) ... existing vaccines so that they can protect people during a ... ,killer T-cell, is the hit-man of the immune system. It ... body, helping rid us of infections," the study,s lead author, ...
Cached Medicine News:Health News:Men Who Get Active in Midlife Live Longer 2Health News:Men Who Get Active in Midlife Live Longer 3Health News:Polymer Group, Inc. Announces Fourth Quarter and Year-End 2008 Earnings Conference Call 2Health News:New Study Finds Text-Messaging Reminders Effective in Improving Adherence to Sunscreen Use 2Health News:New Study Finds Text-Messaging Reminders Effective in Improving Adherence to Sunscreen Use 3Health News:New Study Finds Text-Messaging Reminders Effective in Improving Adherence to Sunscreen Use 4Health News:SETO Holdings, Inc. Signs Letter of Intent to Dispose of all its Existing Businesses and Acquire Advanced Hearing Centers, Inc.; New Management to be Installed. 2
Used for the introduction of catheters, balloons and other vascular devices....
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used for contralateral access to the iliac artery for interventional procedures after initial wire guide positioning has been established....
Used to introduce balloon, electrode, closed or non-tapered end and other catheters....
Medicine Products: